Meritage Portfolio Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$15.5M Sell
74,789
-1,967
-3% -$389K 1.03% 15
2025
Q3
$14.2M Sell
76,756
-4,169
-5% -$714K 0.95% 19
2025
Q2
$12.4M Sell
80,925
-2,960
-4% -$455K 0.78% 27
2025
Q1
$13.9M Sell
83,885
-1,844
-2% -$289K 0.92% 25
2024
Q4
$12.4M Buy
85,729
+5,399
+7% +$837K 0.77% 31
2024
Q3
$13M Sell
80,330
-1,703
-2% -$271K 0.8% 23
2024
Q2
$12M Buy
82,033
+11,907
+17% +$1.77M 0.76% 23
2024
Q1
$11.1M Buy
70,126
+14,906
+27% +$2.37M 0.71% 29
2023
Q4
$8.65M Buy
55,220
+2,473
+5% +$379K 0.57% 41
2023
Q3
$8.21M Sell
52,747
-1,483
-3% -$245K 0.61% 44
2023
Q2
$8.98M Sell
54,230
-2,954
-5% -$477K 0.64% 34
2023
Q1
$8.86M Sell
57,184
-8
-0% -$1.29K 0.66% 36
2022
Q4
$10.1M Sell
57,192
-377
-0.7% -$65.1K 0.79% 25
2022
Q3
$9.4M Sell
57,569
-1,425
-2% -$241K 0.78% 23
2022
Q2
$10.5M Buy
58,994
+714
+1% +$127K 0.81% 24
2022
Q1
$10.3M Buy
58,280
+21,448
+58% +$3.65M 0.64% 34
2021
Q4
$6.3M Buy
36,832
+63
+0.2% +$10.3K 0.36% 82
2021
Q3
$5.94M Sell
36,769
-51
-0.1% -$8.7K 0.36% 76
2021
Q2
$6.07M Sell
36,820
-61,189
-62% -$10.1M 0.37% 79
2021
Q1
$16.1M Buy
98,009
+1,967
+2% +$318K 1.07% 21
2020
Q4
$15.1M Buy
96,042
+2,986
+3% +$441K 1.11% 20
2020
Q3
$13.9M Sell
93,056
-136
-0.1% -$20.1K 1.24% 18
2020
Q2
$13.1M Buy
93,192
+2,029
+2% +$296K 1.26% 22
2020
Q1
$12M Sell
91,163
-3,609
-4% -$512K 1.62% 10
2019
Q4
$13.8M Sell
94,772
-49,368
-34% -$6.7M 1.22% 12
2019
Q3
$18.6M Buy
144,140
+22,565
+19% +$2.97M 1.77% 9
2019
Q2
$16.9M Buy
121,575
+55,772
+85% +$7.72M 1.72% 10
2019
Q1
$9.2M Sell
65,803
-1,053
-2% -$141K 0.93% 25
2018
Q4
$8.63M Sell
66,856
-817
-1% -$114K 0.98% 20
2018
Q3
$9.35M Sell
67,673
-41,003
-38% -$5.45M 0.86% 19
2018
Q2
$13.2M Sell
108,676
-176
-0.2% -$22K 1.28% 7
2018
Q1
$13.9M Buy
108,852
+1,007
+0.9% +$136K 1.35% 11
2017
Q4
$15.1M Sell
107,845
-3,427
-3% -$477K 1.44% 10
2017
Q3
$14.5M Buy
111,272
+668
+0.6% +$88.6K 1.42% 11
2017
Q2
$14.6M Sell
110,604
-2,661
-2% -$339K 1.5% 10
2017
Q1
$14.1M Sell
113,265
-490
-0.4% -$58.5K 1.48% 11
2016
Q4
$13.1M Sell
113,755
-25
-0% -$2.89K 1.43% 9
2016
Q3
$13.4M Sell
113,780
-987
-0.9% -$120K 1.47% 10
2016
Q2
$13.9M Sell
114,767
-1,133
-1% -$129K 1.56% 7
2016
Q1
$12.5M Sell
115,900
-1,436
-1% -$149K 1.42% 10
2015
Q4
$12.1M Buy
117,336
+230
+0.2% +$23.1K 1.36% 6
2015
Q3
$10.9M Buy
117,106
+3,090
+3% +$299K 1.27% 6
2015
Q2
$11.1M Buy
114,016
+1,231
+1% +$123K 1.17% 4
2015
Q1
$11.3M Buy
112,785
+4,475
+4% +$455K 1.14% 5
2014
Q4
$11.3M Buy
108,310
+32,865
+44% +$3.46M 1.2% 6
2014
Q3
$8.04M Buy
75,445
+30,251
+67% +$3.14M 0.92% 10
2014
Q2
$4.73M Buy
45,194
+42,005
+1,317% +$4.25M 0.51% 95
2014
Q1
$313K Hold
3,189
0.04% 190
2013
Q4
$292K Hold
3,189
0.04% 187
2013
Q3
$276K Sell
3,189
-1,300
-29% -$117K 0.04% 191
2013
Q2
$385K Buy
+4,489
New +$381K 0.06% 181

Other funds holding JNJ

Meritage Portfolio Management's JNJ Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Johnson & Johnson (JNJ) stake by 2.6% in Q4 2025, selling an estimated $389K and leaving 74,789 shares worth $15.5M. The position accounts for 1.03% of the portfolio, ranked #15.

Meritage Portfolio Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.6M in Q3 2019. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Meritage Portfolio Management held 74,789 shares of Johnson & Johnson worth $15.5M as of Q4 2025.
  • Meritage Portfolio Management sold 1,967 Johnson & Johnson shares in Q4 2025, an estimated $389K.
  • Johnson & Johnson made up 1.03% of Meritage Portfolio Management's portfolio in Q4 2025, its #15 holding.
  • Meritage Portfolio Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Meritage Portfolio Management's Johnson & Johnson position peaked at $18.6M in Q3 2019.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.